medline.ch Onkologie Gynäkologische Tumoren

	Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer. BMC Cancer Ihlamur M, Demi, Zorba AP, Abamor E, Ba, Allahverdi. PMID: 42106673 [PubMed - as supplied by publisher]
	Integrated Magnetophoretic-Electrochemical platforms for portable detection of HER2 in breast cancer diagnosis. Biosens Bioelectron Anekrattanasap A, Park J, Villarini N, Fukana N, Rai AJ, Siangproh W, Baldo TA, Henry CS. PMID: 42105575 [PubMed - as supplied by publisher]
	Factors influencing information overload among breast cancer patients in the information explosion era: a cross-sectional study. Support Care Cancer Wei J, Liu E, Xie J, Wang P, Bai Z, Jiang H, Xiong Y, Bai L, Zhou J. PMID: 42105010 [PubMed - indexed for MEDLINE]
	Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study. J Clin Lab Anal Yang CZ, Qin LH, Huang CC, Huang XL, Yang YX, Lan W, Fan M. PMID: 42104642 [PubMed - as supplied by publisher]
	The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer. Cancer Med Ruggeri SY, Russell Lippincott CL, Alexander GL, Bartlett Ellis RJ, Chesnut SR, Erickson LA. PMID: 42104589 [PubMed - indexed for MEDLINE]
	The risk of ovarian malignancy algorithm for ovarian cancer in premenopausal and postmenopausal women: A systematic review and meta-analysis. Women Health Zhong D, Li J, Guo G. PMID: 42104563 [PubMed - as supplied by publisher]
	Leveraging immune and clinicopathological profiles with machine learning to predict axillary lymph node metastasis in breast cancer patients. Breast Cancer Res Fischer-Carles A, Fiorin A, López Pablo C, Reverté L, Sauras-Colón E, Gallardo-Borràs N, Lejeune M, Relloso Ortiz de Uriarte M, Sánchez-Alcántara T, Ballester-Navarro M, Bosch Príncep R, Adalid-Llansa L, Goyda E, Mata Cano D, Noailly J, Piella G. PMID: 42104431 [PubMed - as supplied by publisher]
	Omission of completion axillary dissection in clinically node-negative breast cancer with 1-2 metastatic sentinel lymph nodes. World J Surg Oncol Qiao W, Guo X, Li P, Liu Q, Deng M. PMID: 42104353 [PubMed - as supplied by publisher]
	Likelihood of breast cancer among women presenting with breast-related symptoms in primary care, with a focus on isolated mastalgia: a retrospective cohort study. BMC Prim Care van Ieperen SKL, van de Laar FA, Akkermans RP, A Uijen A. PMID: 42104316 [PubMed - as supplied by publisher]
	Severe anemia as a risk factor in Japanese patients with ovarian cancer receiving olaparib: a retrospective study. BMC Cancer Yamaoka K, Kume M, Matsumoto A, Hirabatake M, Hayashi N, Shimizu T, Aoki T, Muroi N. PMID: 42104280 [PubMed - as supplied by publisher]
	Ensemble machine learning algorithms leveraged on serum proteomics for enhanced early detection of ovarian cancer. Sci Rep Ding J, Dong X, Cao L, Zhao L, Ding J, Wang B, Li Y, Liu Z, Han L, Li W, Zhang W, Wang X, Guo B, Huang C, Li X, Guo A, Song L. PMID: 42103875 [PubMed - as supplied by publisher]
	Commentary on Editorial: Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B51 Trial Who Achieve ypN0 After Neoadjuvant Chemotherapy. Pract Radiat Oncol Haffty BG. PMID: 42103409 [PubMed - in process]
	Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B-51 Trial Who Achieve ypN0 After Neoadjuvant Chemotherapy. Pract Radiat Oncol Li PC, Recht A. PMID: 42103408 [PubMed - in process]
	Methylation Marks Breast Cancer Metastasis: The Roles of m(6)A-Modified miRNAs and lncRNAs. J Biol Chem Humphries BA, Wang Z, Yang C. PMID: 42103211 [PubMed - as supplied by publisher]
	The VEGF/VEGFR axis in triple-negative breast cancer: a comprehensive review of therapeutic strategies. Gene Han MI, Atalay P, Satir-Basaran G. PMID: 42103175 [PubMed - as supplied by publisher]
	Is platinum the New gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies. J Control Release Roa AP, Muthuramalingam RPK, Lopez-Sanchez A, Deng LW, Gibson D, Bertrand HC, Adriani G, Ang WH, Pastorin G. PMID: 42103028 [PubMed - as supplied by publisher]
	Risk, prevalence and survival outcomes of ovarian cancer in women with endometriosis: the ENDOCANCER systematic review and meta-analysis. J Minim Invasive Gynecol Piacenti I, Tius V, Gomba B, Restaino S, Arcieri M, Zermano S, Biasioli A, Perelli F, Raimondo D, Lazzeri L, Mattei A, Zupi E, Seracchioli R, Vizzielli G. PMID: 42102910 [PubMed - as supplied by publisher]
	Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis. Gynecol Oncol Lukey A, Salmanpour A, Kaur P, Berchuck A, Chase A, Dawson L, Grout B, Deurloo CM, Richardson J, Stuart G, Terry KL, Webb PM, Pike MC, Pearce CL, Hanley GE. PMID: 42102524 [PubMed - as supplied by publisher]
	Unique Considerations in Rare Gynecologic Tumors: Gestational Trophoblastic Neoplasia, Germ Cell Tumors, and Clear Cell Ovarian Cancers. Am Soc Clin Oncol Educ Book Farley JH, Fujiwara K, Lee JY, Tan DSP, Horowitz NS. PMID: 42102342 [PubMed - indexed for MEDLINE]
	An exploratory dosimetric and treatment-time analysis of tangent-arc and continuous semi-arc VMAT in deep inspiration breath-hold radiotherapy for stage I left-sided breast cancer. PLoS One Li Y, Chen Y, Xu C, Zhan W, Shao K, Jia Y, Zhang H, Qiu L, Ding J, Chen W. PMID: 42102159 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 328400

Seite 1 von 16420

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung